Titre:
  • Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapy
Auteur:De Cock, Emile; Hutton, John; Canney, Peter; Body, Jean-Jacques; Barrett-Lee, Peter; Neary, M.P.; Lewis, Gavin
Informations sur la publication:Supportive care in cancer, 13, 12, page (975-986)
Statut de publication:Publié, 2005-12
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Cost-effectiveness
Ibandronate
Metastatic bone disease
Skeletal-related events
Zoledronic acid
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0941-4355
info:doi/10.1007/s00520-005-0828-1
info:scp/27744466365
info:pmid/15871033